Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma-Reference-Cited by-同舟云学术

Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma

Published:2006-02-01 Issue:3 Volume:106 Page:541-551
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Garcia-Aranda Cristina,de Juan Carmen,Diaz-Lopez Antonio,Sanchez-Pernaute Andres,Torres Antonio-Jose,Diaz-Rubio Eduardo,Balibrea Jose-Luis,Benito Manuel,Iniesta Pilar

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. Genetic predisposition to colorectal cancer

2. , . Cancer of the colon and cancer of the rectum. In: , , editors. Cancer: principles and practice of oncology, 5th ed. Philadelphia: J.B. Lippincott Company, 1997: 1144–1228.

3. Telomere maintenance and cancer ? look, no telomerase

4. Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy;Cancers;2024-05-24

2. GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma;Computational and Mathematical Methods in Medicine;2022-09-14

3. Relative Telomere Length Change in Colorectal Carcinoma and Its Association with Tumor Characteristics, Gene Expression and Microsatellite Instability;Cancers;2022-04-30

4. Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs;Medical Oncology;2021-11-15

5. Current Understanding of Epigenetics Driven Therapeutic Strategies in Colorectal Cancer Management;Endocrine, Metabolic & Immune Disorders - Drug Targets;2021-10